Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Yen Cheng

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Thescientificworldjournal|March 28, 2014
A neural-network-based approach to white blood cell classificationMu-Chun Su, Chun-Yen Cheng, Pa-Chun Wang
Optics Letters|March 30, 2007
Cesium 6S(1/2) --> 8S(1/2) two-photon-transition-stabilized 822.5 nm diode laserChun-Yen Cheng, Chien-Ming Wu, Guan Bo Liao, et al.
Analytical Chemistry|September 6, 2024
High-Resolution Intact Protein Analysis via Phase-Modulated, Stepwise Frequency Scan Ion Trap Mass SpectrometryFang-Hsu Chen, Chun-Yen Cheng, Szu-Wei Chou, et al.
Open Forum Infectious Diseases|January 29, 2020
A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)Juan P Horcajada, Robert A Salata, Rodolfo Álvarez-Sala, et al.
Journal of the American Society for Mass Spectrometry|December 15, 2016
High Mass Ion Detection with Charge Detector Coupled to Rectilinear Ion Trap Mass SpectrometerAvinash A Patil, Szu-Wei Chou, Pei-Yu Chang, et al.
Studies in Health Technology and Informatics|August 8, 2025
Exploring Machine Learning for Predicting Peripheral and Central Precocious Puberty Through Cross-Hospital ValidationChun-Yen Cheng, Yung-Chun Chang, Nguyen Quoc Khanh Le, et al.
Talanta|April 23, 2023
Development of a linear ion trap mass spectrometer capable of analyzing megadalton MALDI ionsAvinash A Patil, Zhe-Xuan Liu, Yi-Pang Chiu, et al.
Annals of Clinical and Translational Neurology|March 27, 2026
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial ParticipantsRalf Gold, Krzysztof W Selmaj, Regina Berkovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trialRobert T Naismith, Jeffrey A Cohen, Amit Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2022
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trialBruce Ac Cree, Krzysztof W Selmaj, Lawrence Steinman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Thescientificworldjournal|March 28, 2014
A neural-network-based approach to white blood cell classificationMu-Chun Su, Chun-Yen Cheng, Pa-Chun Wang
Optics Letters|March 30, 2007
Cesium 6S(1/2) --> 8S(1/2) two-photon-transition-stabilized 822.5 nm diode laserChun-Yen Cheng, Chien-Ming Wu, Guan Bo Liao, et al.
Analytical Chemistry|September 6, 2024
High-Resolution Intact Protein Analysis via Phase-Modulated, Stepwise Frequency Scan Ion Trap Mass SpectrometryFang-Hsu Chen, Chun-Yen Cheng, Szu-Wei Chou, et al.
Open Forum Infectious Diseases|January 29, 2020
A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)Juan P Horcajada, Robert A Salata, Rodolfo Álvarez-Sala, et al.
Journal of the American Society for Mass Spectrometry|December 15, 2016
High Mass Ion Detection with Charge Detector Coupled to Rectilinear Ion Trap Mass SpectrometerAvinash A Patil, Szu-Wei Chou, Pei-Yu Chang, et al.
Studies in Health Technology and Informatics|August 8, 2025
Exploring Machine Learning for Predicting Peripheral and Central Precocious Puberty Through Cross-Hospital ValidationChun-Yen Cheng, Yung-Chun Chang, Nguyen Quoc Khanh Le, et al.
Talanta|April 23, 2023
Development of a linear ion trap mass spectrometer capable of analyzing megadalton MALDI ionsAvinash A Patil, Zhe-Xuan Liu, Yi-Pang Chiu, et al.
Annals of Clinical and Translational Neurology|March 27, 2026
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial ParticipantsRalf Gold, Krzysztof W Selmaj, Regina Berkovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trialRobert T Naismith, Jeffrey A Cohen, Amit Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2022
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trialBruce Ac Cree, Krzysztof W Selmaj, Lawrence Steinman, et al.
Pageof 2